Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Incidence, severity and treatment outcome of tuberculosis in the era of the COVID-19 pandemic, France, 2018-2023.
J Epidemiol Popul Health
January 2025
Santé publique France, Direction des maladies infectieuses, Saint-Maurice, France.
Introduction: In France, the average steady decline in tuberculosis (TB) incidence close to 5 % per year over the past half-century has been occasionally interrupted by disruptions related to external events. We describe the impact of the COVID-19 pandemic on TB incidence, severity and treatment outcome.
Methods: We analysed the number of TB cases and treatment outcomes reported through the mandatory notification system through 2018-2023.
Burden of Cardio-Cerebrovascular and Renal Diseases Attributable to Systolic Hypertension in France in 2021.
Hypertension
February 2025
Direction des maladies non transmissibles, Santé publique France, Saint-Maurice, France (C.G., A.G., M.J.T., V.O.).
Background: Hypertension is the most common chronic disease and a major modifiable risk factor for cardio-cerebrovascular and renal diseases. This study estimated the national burden of hypertension, defined as systolic blood pressure ≥140 mm Hg, on morbidity and mortality in 2021 in France.
Methods: For all diseases causally associated with hypertension (cardiovascular diseases, chronic kidney diseases, and dementia), the number and proportion of cases attributable to hypertension in adults aged ≥35 years were estimated using population attributable fractions.
Design and validation of Withings ECG Software 2, a tiny neural network based algorithm for detection of atrial fibrillation.
Comput Biol Med
December 2024
Withings, 2 rue Maurice Hartmann, Issy-les-Moulineaux, 92130, France.
Background: Atrial Fibrillation (AF) is the most common form of arrhythmia in the world with a prevalence of 1%-2%. AF is also associated with an increased risk of cardiovascular diseases (CVD), such as stroke, heart failure, and coronary artery diseases, making it a leading cause of death. Asymptomatic patients are a common case (30%-40%).
View Article and Find Full Text PDFEpidemiology of valvular heart disease in France.
Arch Cardiovasc Dis
December 2024
Santé Publique France, 94410 Saint-Maurice, France.
Background: Demographic changes and improvements in the diagnosis and treatment of valvular heart diseases (VHDs) have led to changes in its epidemiological profile.
Aims: To describe the epidemiology of VHD in France in 2022.
Methods: Adults hospitalized due to VHD in 2022 were identified from the French National Health Data System and categorized by type of VHD on the basis of hospital diagnoses and interventions.
Estimation of the proportion of cardiovascular disease cases in France attributable to high concentrations of low-density lipoprotein cholesterol.
Arch Cardiovasc Dis
December 2024
Santé Publique France, 94410 Saint-Maurice, France.
Background: Elevated concentrations of low-density lipoprotein cholesterol (LDL-C) are highly prevalent and are associated with the development of cardiovascular diseases.
Aim: To estimate the proportion of cardiovascular disease cases attributable to high concentrations of LDL-C (population attributable fraction [PAF]) in France in 2017, based on the most recent individual data on LDL-C, and the attributable burden on hospitalizations and death.
Methods: We estimated the PAF of high LDL-C concentrations for ischaemic heart disease (IHD), ischaemic stroke and aortic valve stenosis (AVS).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!